Process Research and Development for an Efficient Synthesis of the HIV Protease Inhibitor BMS-232632
- 20 April 2002
- journal article
- research article
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 6 (3) , 323-328
- https://doi.org/10.1021/op025504r
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- A Novel, Chemoselective and Efficient Production of Amines from Azides Using ZrCl4/NaBH4Synthetic Communications, 2000
- In Vitro Resistance Profile of the Human Immunodeficiency Virus Type 1 Protease Inhibitor BMS-232632Antimicrobial Agents and Chemotherapy, 2000
- BMS-232632, a Highly Potent Human Immunodeficiency Virus Protease Inhibitor That Can Be Used in Combination with Other Available Antiretroviral AgentsAntimicrobial Agents and Chemotherapy, 2000
- Arzoxifene hydrochlorideDrugs of the Future, 1999
- New Aza-Dipeptide Analogues as Potent and Orally Absorbed HIV-1 Protease Inhibitors: Candidates for Clinical DevelopmentJournal of Medicinal Chemistry, 1998
- Aza-Peptide Analogs as Potent Human Immunodeficiency Virus Type-1 Protease Inhibitors with Oral BioavailabilityJournal of Medicinal Chemistry, 1996
- Nucleosides and Nucleotides. 151. Conversion of (Z)-2‘-(Cyanomethylene)-2‘-deoxyuridines into Their (E)-Isomers via Addition of Thiophenol to the Cyanomethylene Moiety Followed by Oxidative Syn-elimination Reactions1The Journal of Organic Chemistry, 1996
- Synthetic studies on oxetanocin analogs: synthesis of oxetanosyl C-nucleoside, 2-deoxy-2-hydroxymethyl-β-D-erythrooxetanosyl maleimideTetrahedron Letters, 1991
- Glycosyl-inositol derivativesTetrahedron, 1991
- 1.8‐Dehydro‐naphthalin, IEuropean Journal of Organic Chemistry, 1967